Chemokine Receptor 5 Antagonism Causes Reduction in Joint Inflammation in a Collagen-Induced Arthritis Mouse Model
Rheumatoid arthritis (RA) is a chronic inflammatory disease mainly affecting the synovial joints. A highly potent antagonist of C-C chemokine receptor 5 (CCR5), maraviroc (MVC), plays an essential role in treating several infectious diseases but has not yet been evaluated for its potential effects o...
Main Authors: | Mushtaq A. Ansari, Ahmed Nadeem, Saleh A. Bakheet, Sabry M. Attia, Mudassar Shahid, Faris S. Alyousef, Mohammed A. Alswailem, Mohammed Alqinyah, Sheikh F. Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/7/1839 |
Similar Items
-
Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
by: A V Kravchenko
Published: (2013-11-01) -
Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines
by: Jiaqi Yang, et al.
Published: (2021-03-01) -
CCR5 is a novel target for the treatment of experimental alopecia areata
by: Taisuke Ito, et al.
Published: (2020-04-01) -
Clinical impact of tropism testing in a real-life cohort of HIV infected patients: a retrospective observational study
by: Laurène Deconinck, et al.
Published: (2019-05-01) -
CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
by: Metka Novak, et al.
Published: (2020-06-01)